Holen Sie sich die Stockscreener-App
151.44
1.83%
-2.83
Vorhandelsmarkt:
150.97
-0.47
-0.31%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BIIB?
Forum
Prognose
Aktiensplit
Biogen Inc Aktie (BIIB) Neueste Nachrichten
Recombinant DNA Technology Market Surges with Breakthrough - openPR.com
Biogen Inc. $BIIB Shares Sold by iA Global Asset Management Inc. - MarketBeat
Behavioral Patterns of BIIB and Institutional Flows - news.stocktradersdaily.com
Historical volatility pattern of Biogen Inc. visualized2025 Market Overview & Trade Opportunity Analysis - newser.com
BIIB: Bernstein Raises Price Target for Biogen to $157 with Mark - GuruFocus
Biogen to present felzartamab data at Kidney Week 2025 - Investing.com
Biogen (BIIB) Reveals New Data on Felzartamab at Kidney Week 202 - GuruFocus
Why Biogen Inc. (IDP) stock stays on top picksJuly 2025 Patterns & AI Powered Market Entry Strategies - newser.com
Biogen Inc. to Present Groundbreaking Longitudinal Gene Expression Data on Felzartamab at Kidney Week 2025 - Quiver Quantitative
Biogen Inc. $BIIB Shares Bought by State of Michigan Retirement System - MarketBeat
Plato Investment Management Ltd Raises Stock Holdings in Biogen Inc. $BIIB - MarketBeat
FY2025 EPS Estimates for Biogen Decreased by Leerink Partnrs - MarketBeat
Should you wait for a breakout in Biogen Inc.2025 Key Lessons & Smart Money Movement Tracker - newser.com
How to escape a deep drawdown in Biogen Inc.Portfolio Update Summary & High Conviction Buy Zone Alerts - newser.com
Amgen Earnings: What To Look For From AMGN - FinancialContent
Is Biogen Inc. stock a safe buy before earningsRisk Management & High Conviction Trade Alerts - newser.com
Biogen (NASDAQ:BIIB) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat
Guggenheim Increases Biogen (NASDAQ:BIIB) Price Target to $185.00 - MarketBeat
Biogen (NASDAQ:BIIB) Given New $150.00 Price Target at BMO Capital Markets - MarketBeat
Biogen (NASDAQ:BIIB) Price Target Raised to $143.00 - MarketBeat
Biotech Investments Market Seeking Excellent Growth | Biogen (US), Moderna, Johnson & Johnson - openPR.com
How a Strong Q3 and Increased R&D Spending at Biogen (BIIB) Has Changed Its Investment Story - simplywall.st
Biogen shares drop as full-year guidance cut outweighs strong Q3 results - MSN
Institutional scanner results for Biogen Inc.2025 Major Catalysts & Community Verified Swing Trade Signals - newser.com
Published on: 2025-11-02 04:50:47 - newser.com
Savvy Advisors Inc. Buys New Holdings in Biogen Inc. $BIIB - MarketBeat
Biogen Inc. $BIIB Stock Holdings Increased by Wealthfront Advisers LLC - MarketBeat
Biogen (NASDAQ:BIIB) Stock Rating Lowered by Wall Street Zen - MarketBeat
Biogen Inc. (NASDAQ:BIIB) Q3 2025 Earnings Call Transcript - Insider Monkey
Biogen’s Earnings Call Highlights Robust Growth and Positive Outlook - The Globe and Mail
Key metrics from Biogen Inc.’s quarterly dataWeekly Profit Recap & Precise Swing Trade Entry Alerts - newser.com
Royal Bank Of Canada Lowers Biogen (NASDAQ:BIIB) Price Target to $210.00 - MarketBeat
Biogen (NASDAQ:BIIB) Price Target Cut to $250.00 by Analysts at Robert W. Baird - MarketBeat
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Biogen (BIIB), Option Care Health (OPCH) and Amneal Pharmaceuticals (AMRX) - The Globe and Mail
Biogen outlines 67% launch product growth and signals expanded pipeline momentum amid strong Q3 results - MSN
Sector ETF performance correlation with Biogen Inc.Trade Analysis Report & Consistent Profit Focused Trading Strategies - newser.com
Fjarde AP Fonden Fourth Swedish National Pension Fund Has $3.44 Million Stake in Biogen Inc. $BIIB - MarketBeat
Analyzing Biogen Inc. with multi timeframe chartsTrade Volume Summary & Long-Term Growth Plans - newser.com
Is Biogen Inc. stock a top momentum playWeekly Trend Recap & Reliable Intraday Trade Plans - newser.com
Biogen Inc. Reports Strong Q3 2025 Results - The Globe and Mail
Biogen (NASDAQ:BIIB) Issues Earnings Results - MarketBeat
BMO Capital Adjusts Biogen Price Target to $150 From $128 - MarketScreener
Biogen (BIIB) Rating Maintained as RBC Capital Lowers Price Targ - GuruFocus
BIIB Q3 Deep Dive: New Product Launches Offset Guidance Cut, R&D Pipeline Expands - Yahoo Finance
Wedbush Raises Price Target on Biogen to $143 From $135, Keeps Neutral Rating - MarketScreener
Wells Fargo Adjusts Price Target on Biogen to $155 From $140 - MarketScreener
Baird Adjusts Price Target on Biogen to $250 From $255 - MarketScreener
Biogen (NASDAQ:BIIB) Issues FY 2025 Earnings Guidance - MarketBeat
Biogen (BIIB): One-Time $471M Loss Raises Fresh Doubts Over Rebounding Profit Narrative - Yahoo Finance
RBC Cuts Price Target on Biogen to $210 From $217, Keeps Outperform Rating - MarketScreener
Volatility clustering patterns for Biogen Inc.Market Activity Summary & Fast Gain Swing Alerts - newser.com
Emerald Advisers LLC Makes New Investment in Biogen Inc. $BIIB - MarketBeat
Biogen Lowers Outlook Even As Profits And Sales Top Estimates - Finimize
How Biogen Inc. (IDP) stock behaves in tightening cyclesStock Surge & Low Risk High Reward Trade Ideas - newser.com
When is the best time to exit Biogen Inc.July 2025 Volume & Free Community Supported Trade Ideas - newser.com
Biogen stock price target raised to $185 from $165 at Guggenheim - Investing.com
Biogen Inc (BIIB) Q3 Earnings: EPS of $3.17 Beats Estimates, Rev - GuruFocus
An Early-Career Stand Proved This Young Biotech Exec Had What It Takes - BioSpace
Biogen (BIIB) Valuation: Exploring the Discount as Investor Sentiment Shifts - Yahoo Finance
Biogen’s Innovative Approach to SMA Treatment: A Study Update - TipRanks
Decoding Biogen Inc (BIIB): A Strategic SWOT Insight - GuruFocus
Biogen’s New Study on Felzartamab: A Potential Game-Changer for Kidney Transplant Patients - TipRanks
Biogen (BIIB) Net Margin Surges to 15.3%, Challenging Bearish Profitability Narratives After One-Off Loss - simplywall.st
1.05%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):